Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients

August 31, 2023 updated by: Riphah International University

Effects of Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients

To determine the effects of scapular mobilization on pulmonary functions of post-CABG patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • KPK
      • Peshawar, KPK, Pakistan, 46000
        • Rehman Medical Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • CAD patients undergone CABG surgery (Post-Op. Day#. 01).
  • Both genders (male and female).
  • Aged between 40 to 70 years .
  • Patient having oxygen saturation (SPO2) of more than or equal to 90% with 25% of fraction of inspired oxygen (FiO2) - (possibly nasal cannula inserted).

Exclusion Criteria:

  • Patients with low glasgow coma scale (GCS) score (less than 15).
  • Patients having inspiratory capacity of 3500ml and above.
  • Patients on ventilator.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional Treatment
Thrice a day ,Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.
Other: Conventional Treatment
Thrice a day for complete length of stay. This is Conventional treatment The total duration of session will be of 15-20 mins.
Experimental: Scapular Mobilization
Thrice a day Scapular mobilization (SM) along with Conventional treatment
Other: Scapular Mobilization
Thrice a day for complete length of stay including two sets of repetitions with a rest interval of 30 seconds between sets. Grade 1-3 As reported in a study Scapular mobilization (SM) i.e., Scapular superior, inferior glides, upward and downward rotations and scapular distraction, along with Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incentive Spirometer
Time Frame: 1 week
An incentive spirometer is a device that will expand the lungs by helping the patient breathe more deeply and fully
1 week
Borg scale
Time Frame: 1 week
The Borg Rating of Perceived Exertion (RPE) is a way of measuring physical activity intensity level.
1 week
Numeric pain rating scale
Time Frame: 1 week
What is a numerical pain rating scale? The Numerical Pain Rating Scale (NPRS) is a subjective measure in which individuals rate their pain
1 week
Digital Spirometer
Time Frame: 1 week
Spirometer is a portable lung function testing device, which mainly used to examine lung function related parameters for patients
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Malik Muhammad Ali Awan, MSPT, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2022

Primary Completion (Actual)

February 10, 2023

Study Completion (Actual)

July 1, 2023

Study Registration Dates

First Submitted

March 8, 2022

First Submitted That Met QC Criteria

March 8, 2022

First Posted (Actual)

March 18, 2022

Study Record Updates

Last Update Posted (Actual)

September 1, 2023

Last Update Submitted That Met QC Criteria

August 31, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/01278 Sakina Asghar

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on CABG

Clinical Trials on Conventional Treatment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe